144 related articles for article (PubMed ID: 28715026)
1. Exchangeable proton ENDOR as a probe of the redox-active iron center in activated bleomycin and ferric bleomycin.
Burger RM; Grigoryants VM; Scholes CP
Dalton Trans; 2017 Oct; 46(39):13263-13272. PubMed ID: 28715026
[TBL] [Abstract][Full Text] [Related]
2. Cryogenic photolysis of activated bleomycin to ferric bleomycin.
Burger RM; Usov OM; Grigoryants VM; Scholes CP
J Phys Chem B; 2006 Oct; 110(41):20702-9. PubMed ID: 17034262
[TBL] [Abstract][Full Text] [Related]
3. Orientation of iron bleomycin and porphyrin complexes on DNA fibers.
Chikira M; Iiyama T; Sakamoto K; Antholine WE; Petering DH
Inorg Chem; 2000 Apr; 39(8):1779-86. PubMed ID: 12526568
[TBL] [Abstract][Full Text] [Related]
4. Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methods.
Liu LV; Bell CB; Wong SD; Wilson SA; Kwak Y; Chow MS; Zhao J; Hodgson KO; Hedman B; Solomon EI
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22419-24. PubMed ID: 21149675
[TBL] [Abstract][Full Text] [Related]
5. Further insights into the mechanism of the reaction of activated bleomycin with DNA.
Chow MS; Liu LV; Solomon EI
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13241-5. PubMed ID: 18757754
[TBL] [Abstract][Full Text] [Related]
6. Direct hydrogen-atom abstraction by activated bleomycin: an experimental and computational study.
Decker A; Chow MS; Kemsley JN; Lehnert N; Solomon EI
J Am Chem Soc; 2006 Apr; 128(14):4719-33. PubMed ID: 16594709
[TBL] [Abstract][Full Text] [Related]
7. Structures of HO(2)-Co(III)bleomycin A(2) bound to d(GAGCTC)(2) and d(GGAAGCTTCC)(2): structure-reactivity relationships of Co and Fe bleomycins.
Zhao C; Xia C; Mao Q; Försterling H; DeRose E; Antholine WE; Subczynski WK; Petering DH
J Inorg Biochem; 2002 Jul; 91(1):259-68. PubMed ID: 12121784
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of reaction of DNA-bound Fe(III)bleomycin with ascorbate: interplay of specific and non-specific binding.
Li W; Antholine WE; Petering DH
J Inorg Biochem; 2002 May; 90(1-2):8-17. PubMed ID: 12009250
[TBL] [Abstract][Full Text] [Related]
9. Proton-shuffle mechanism of O-O activation for formation of a high-valent oxo-iron species of bleomycin.
Kumar D; Hirao H; Shaik S; Kozlowski PM
J Am Chem Soc; 2006 Dec; 128(50):16148-58. PubMed ID: 17165768
[TBL] [Abstract][Full Text] [Related]
10. EPR and ENDOR studies of cryoreduced compounds II of peroxidases and myoglobin. Proton-coupled electron transfer and protonation status of ferryl hemes.
Davydov R; Osborne RL; Kim SH; Dawson JH; Hoffman BM
Biochemistry; 2008 May; 47(18):5147-55. PubMed ID: 18407661
[TBL] [Abstract][Full Text] [Related]
11. Fe- and Co-bleomycins bound to site specific and nonspecific DNA decamers: comparative binding and reactivity of their metal centers.
Fulmer P; Zhao C; Li W; DeRose E; Antholine WE; Petering DH
Biochemistry; 1997 Apr; 36(14):4367-74. PubMed ID: 9100034
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific changes in the metal site of ferric bleomycin induced by the binding of DNA.
Sam JW; Takahashi S; Lippai I; Peisach J; Rousseau DL
J Biol Chem; 1998 Jun; 273(26):16090-7. PubMed ID: 9632661
[TBL] [Abstract][Full Text] [Related]
13. Interaction of nitrosyl Fe(II) complex of bleomycin with DNA.
Chikira M; Sakamoto K; Antholine WE
Nucleic Acids Symp Ser; 1997; (37):99-100. PubMed ID: 9586018
[TBL] [Abstract][Full Text] [Related]
14. Interactions of iron bleomycin, phosphate or cyanide, and DNA: sequence-dependent conformations and reactions.
Li W; Xia C; Antholine WE; Petering DH
J Biol Inorg Chem; 2001 Jun; 6(5-6):618-27. PubMed ID: 11472025
[TBL] [Abstract][Full Text] [Related]
15. Mössbauer, EPR and NMR studies of the acid-induced reduction and changes in spin state of ferric bleomycin.
Levy A; Manoharan PT; Rifkind JM; Walker JC; Haberle FC; Kumar NG; Glickson JD; Elgavish GA
Biochim Biophys Acta; 1989 Apr; 991(1):97-108. PubMed ID: 2469484
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage.
Hoehn ST; Junker HD; Bunt RC; Turner CJ; Stubbe J
Biochemistry; 2001 May; 40(20):5894-905. PubMed ID: 11352724
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for VO(2+)-inhibition of nitrogenase activity: (B) pH-sensitive inner-sphere rearrangements in the 1H-environment of the metal coordination site of the nitrogenase Fe-protein identified by ENDOR spectroscopy.
Petersen J; Mitchell CJ; Fisher K; Lowe DJ
J Biol Inorg Chem; 2008 May; 13(4):637-50. PubMed ID: 18386081
[TBL] [Abstract][Full Text] [Related]
18. An active intermediate formed in the reaction of bleomycin-Fe(II) complex with oxygen.
Kuramochi H; Takahashi K; Takita T; Umezawa H
J Antibiot (Tokyo); 1981 May; 34(5):576-82. PubMed ID: 6168629
[TBL] [Abstract][Full Text] [Related]
19. Comparative binding properties of metallobleomycins with DNA 10-mers.
Li W; Zhao C; Xia C; Antholine WE; Petering DH
Biochemistry; 2001 Jun; 40(25):7559-68. PubMed ID: 11412110
[TBL] [Abstract][Full Text] [Related]
20. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
Mahmutoglu I; Kappus H
Mol Pharmacol; 1988 Oct; 34(4):578-83. PubMed ID: 2459594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
